Celltrion
068270.KS
#859
Rank
C$37.30 B
Marketcap
C$170.53
Share price
-1.10%
Change (1 day)
0.13%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): C$2.64

According to Celltrion 's latest financial reports the company's current EPS (TTM) is C$2.59. In 2023 the company made an earnings per share (EPS) of C$3.78 a decrease over its 2022 EPS that were of C$3.86.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$2.64
2023C$3.78-2.08%
2022C$3.86-11.72%
2021C$4.382.03%
2020C$4.2982.8%
2019C$2.3518.31%
2018C$1.98-36.33%
2017C$3.12161.25%
2016C$1.192.86%
2015C$1.1617.84%
2014C$0.985.87%
2013C$0.93-70.85%
2012C$3.19134.09%
2011C$1.3643.59%
2010C$0.9574.49%
2009C$0.54317.8%
2008C$0.13-71.7%
2007C$0.46